
Dr. Sheri Prentiss shares how early detection and patient advocacy can prevent chronic lymphedema and improve quality of life for cancer survivors.

Dr. Sheri Prentiss shares how early detection and patient advocacy can prevent chronic lymphedema and improve quality of life for cancer survivors.

An oncology social worker discusses the unique psychosocial challenges younger adults face during cancer treatment and survivorship.

Survivor Kiana Wooten shares her story on genetic testing, overcoming sepsis and why choosing to stay flat was her most empowering medical decision.

My smile today is one of compassion. It’s a smile that welcomes the stranger I meet. It radiates joy and presence.

Press Release
The DONNA Foundation announced a matching gift challenge supporting fundraising efforts for its annual Celebrate Every Mom campaign.

New EGFR-targeting combos may improve response rates and durability for patients with head and neck cancer.

Breast cancer survivor Dr. Sheri Prentiss discusses shifting oncology care from a "wait and see" approach to early lymphedema intervention and advocacy.

Experts highlight the need for tailored care strategies to address fertility, financial strain and survivorship challenges in younger adults with cancer.

Dr. Alexander Meves explains how the Merlin CP-GEP test uses molecular data to help melanoma patients safely avoid unnecessary lymph node surgeries.

A tongue cancer survivor and her oncologist discuss lasting side effects, daily management, self-advocacy and emerging treatment approaches.

Pediatric Cancer Research Foundation CEO Danielle Fragalla discusses the biological differences in pediatric cancer and the need for treatments designed for developing bodies.

Gotistobart reduced risk of death by 54% and doubled 12-month survival vs chemotherapy in advanced squamous NSCLC after prior treatment.

A newly approved all-oral combination for CLL offers patients a fixed-duration option, reducing clinic visits and expanding personalized care.

An expert explains ostomy bags and how new technologies are improving comfort and quality of life after colorectal cancer surgery.

Libtayo improved survival and safety outcomes vs chemotherapy in advanced NSCLC, with 23% of patients alive at six years in the EMPOWER-Lung 1 trial.

Dr. Reshma Jagsi discusses optimizing breast cancer care by safely de-escalating surgery and radiation using patient-centered communication

Once the reality set in that my sister was cancer-free and in remission, I realized I was unprepared for what life would look like after cancer.

Physician Dr. Sheri Prentiss advocates for baseline measurements and proactive surveillance to detect and treat breast cancer-related lymphedema early.

New data highlight colorectal cancer rates in younger adults, emphasizing the need for earlier screening, symptom awareness and timely diagnosis.

Nuvalent submitted an NDA for neladalkib to the FDA for patients with previously treated ALK-positive non-small cell lung cancer, based on ALKOVE-1 trial data showing activity.

Histotripsy uses focused ultrasound to treat liver tumors without surgery, needles or radiation, offering a new non-invasive option for patients.

Dr. Sara Nunnery and Dr. Neil Iyengar discuss metabolic health, GLP-1s and prescribing exercise to improve outcomes for breast cancer survivors.

Dry mouth and neck tightness from oral tongue cancer treatment shape daily life, managed with hydration, stretches, therapies and a head and neck Flexitouch device.

My experience with small lymphocytic lymphoma for the past 16 years has taught me many lessons.

Expanding local access to clinical trials improves options by reducing barriers and bringing research opportunities closer to patients with cancer, Dr. Natalie Berger said.

Following her breast cancer diagnosis, Guerdy Abraira utilized genomic testing to gain clarity on her treatment path.

Diabetes drug metformin may mimic exercise effects in prostate cancer, supporting weight, metabolism and overall health during treatment.

Research shows lifestyle and gut bacteria may drive early-onset colorectal cancer, emphasizing diet and healthy habits to help lower risk.

Learn about inflammatory breast cancer (IBC) diagnosis, aggressive treatment paths, and side effects to better navigate your journey and care plan.

Dr. Robert Coleman explains how Lifyorli plus nab-paclitaxel may help patients with platinum-resistant ovarian cancer control disease and improve survival.